The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

NCT03599284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors

Interventions

DRUG: Vicagrel 5mg
DRUG: Vicagrel 6mg
DRUG: Vicagrel 7.5mg
DRUG: Clopidogrel 75mg

Sponsor

Jiangsu vcare pharmaceutical technology co., LTD